Evaluation of Some Prognostic Factors in Acute Aluminum Phosphide Intoxicated Cases
NCT05215444 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2023-01-26
Summary
study of some laboratory and clinical findings which may show the severity of aluminium phosphide toxicity and the need of the cases to be admitted to ICU
Conditions
- Aluminum Phosphide Poisoning
Interventions
- DIAGNOSTIC_TEST
-
some prognostic factors
cortisol level, renin, troponin I, MDA ,catalase, super oxide dismutase, liver functions, kidney functions, arterial blood gases, sodium level, potassium level. white blood cells count
Sponsors & Collaborators
-
Zagazig University
lead OTHER_GOV
Eligibility
- Min Age
- 15 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2021-01-30
- Completion
- 2021-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
L-Carnitine as an Adjuvant Treatment in Acute Phosphide Poisoning (LC)
NCT03953248 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Role of Intralipid in Management of Organophosphorus Poisoning
NCT04393103 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Role of Intravenous Lipid Emulsion in Improving Coma of Acute Antipsychotics Poisoning
NCT04807634 ·Status: UNKNOWN ·Phase: NA
-
Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS
NCT05153525 ·Status: UNKNOWN ·Phase: PHASE4
-
Application Registration Study of ILE in Patients With Acute Poisoning
NCT05148611 ·Status: UNKNOWN
-
The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block
NCT04934904 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.
NCT04641364 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Spectrum and Outcome of Poisoning in Children Admitted to the Pediatric Emergency and Intensive Care Units at Sohag University Hospital
NCT06447584 ·Status: RECRUITING
-
Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning
NCT06798142 ·Status: ACTIVE_NOT_RECRUITING
-
Fresh Frozen Plasma Transfusion in Acute Organophosphate Poisoning
NCT06256796 ·Status: RECRUITING ·Phase: NA
-
Stepwise Enteral Nutritional Algorithm and Patient Outcomes in Pediatric Intensive Care Units
NCT07307027 ·Status: RECRUITING ·Phase: NA
-
To Study the Effects of Lipid Emulsion on Hemodynamics in Organophosphate Compound Poisoning
NCT03564574 ·Status: COMPLETED ·Phase: PHASE4
-
Timing of Initiation of Parenteral Nutrition for Critically Ill Children
NCT04693143 ·Status: UNKNOWN ·Phase: NA
-
Lipid Infusion in Dialysis Patients With Endotoxemia
NCT00506454 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers
NCT01560702 ·Status: COMPLETED ·Phase: NA
-
Corticosteroid Treatment in the Acute Phase of Caustic Ingestion Management
NCT03760354 ·Status: UNKNOWN ·Phase: PHASE2
-
Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency
NCT04404400 ·Status: RECRUITING ·Phase: PHASE3
-
Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning
NCT02160548 ·Status: COMPLETED ·Phase: PHASE3
-
Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
NCT00512811 ·Status: COMPLETED ·Phase: PHASE3
-
Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex
NCT02932254 ·Status: COMPLETED ·Phase: PHASE4
-
3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency
NCT04228445 ·Status: COMPLETED ·Phase: PHASE3
-
Paraoxonase-1 Pseudo Cholinesterase Organophosphate Toxicity Enzyme in Prediction the Severity and Outcome of Acute Organophosphate Poisoning and Its Correlation With Pseudo Cholinesterase Enzyme Level.
NCT06108557 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessing The Role Of Intravenous Lipid Emulsion As A Life Saving Therapy In Pesticides Toxicity
NCT05006638 ·Status: UNKNOWN ·Phase: PHASE4
-
Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime
NCT06111352 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)
NCT04848779 ·Status: ACTIVE_NOT_RECRUITING